Skip to Content

Revance Therapeutics

RVNC

Buy $RVNC at eToro
Rank 4223
Country USA
Exchange NASDAQ
Currency USD
Sector LIFE SCIENCES
Industry PHARMACEUTICAL PREPARATIONS
Address 7555 GATEWAY BLVD., NEWARK, CA, US

Revance Therapeutics - Key figures

Market cap 1.27 Billion
Revenue 89.76 Million
Profit -61,867,000
P/E Ratio No information
P/s Ratio 14.16
Buy $RVNC at eToro

Revance Therapeutics - Description

Revance Therapeutics, Inc., a biotechnology company, is dedicated to the development, manufacture, and marketing of neuromodulators for various aesthetic and therapeutic indications in the United States and internationally.

The company is headquartered in Newark, California.